profile picture

Gert-Jan Braunstahl

Franciscus Gasthuis & Vlietland

asthma

exacerbations

abpa

allergic bronchopulmonary aspergillosis

dupilumab

inflammation

allergy

respiratory tract infections

bacterial lysates

adult-onset asthma

metabolic syndrome

lipid mediators

immune modulation

type 2 inflammation

covid-19

5

presentations

SHORT BIO

Gert-Jan Braunstahl is a pulmonologist working in a tertiary severe asthma center in Rotterdam with a wide-spread network in the South-West part of the Netherlands. He did part of his scientific and professional training abroad in Canada (McMaster University, Hamilton) and South-Africa (Grote Schuur Hospital, Cape Town). After his training at the ErasmusMC in Rotterdam and completing his thesis on the nasobronchial interaction in allergic rhinitis and asthma, he started working as an asthma specialist in 2006 in the Franciscus Gasthuis & Vlietland hospital. His initial scientific work has significantly contributed to the “united airways” concept. After this the focus has shifted towards clinical application of fractionated nitric oxide (FeNO) in respiratory allergy. Nowadays, he is involved in several lines of research, such as morbid obesity and asthma, aging of the asthmatic lung, bacterial lysates and prevention of asthma exacerbations, and several clinical studies investigating biologicals in asthma. He holds a position as an associate professor at Erasmus MC and is head of the section Asthma and Allergy of the NVALT.

Presentations

Roadmap to improve regional care for severe asthma patients in the Netherlands

Gert-Jan Braunstahl and 8 other authors

Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort

Geertje de Boer and 3 other authors

Prevention of exacerbations in moderate-severe asthma by bacterial lysate add-on therapy: a randomized controlled trial

Geertje de Boer and 8 other authors

Adult but not childhood onset asthma is associated with the metabolic syndrome, independent from body mass

Geertje de Boer and 8 other authors

Case series: asthmatic patients with allergic bronchopulmonary aspergillosis (ABPA) treated with dupilumab

Tjeerd van der Veer and 3 other authors

Stay up to date with the latest Underline news!

Select topic of interest (you can select more than one)

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved